companydata.dkcompanydata.dk

Ranger Biotechnologies A/S: Financial statements 2024

CVR: 32280404

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -223,697 and a net result of DKK -1,138,092 compared with DKK 1,431,531 the year before. Equity in the 2024 report amounted to DKK 1,554,692. The solvency ratio was 97.2%. The company had 1 employee in the financial year.

Gross Profit
DKK -223,697
Profit/Loss
DKK -1,138,092
Equity
DKK 1,554,692
Total Assets
DKK 1,599,078
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--224K-1.1M1.6M1
2023-1.7M1.4M2.7M0
2022-7.1M372K1.3M11
2021-5.7M172K889K9
2020-2.4M0717K3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Ranger Biotechnologies A/S: The 2023 annual report is outJul 1, 2024

Ranger Biotechnologies A/S has published its annual report for 2023. Gross profit came to DKK 1,653,810, and the net result was DKK 1,431,531.

About Ranger Biotechnologies A/S

Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.

Source: annual report 2025, Danish Business Authority